R
59
4
O
20
-6
NUE
39
2
HAL
30
-10
BMY
38
-3
CHRW
51
-2
AMG
49
14
TROW
42
3
QCOM
56
6
EQIX
57
-2
JCI
42
-2
DVN
24
2
FRT
36
2
KLAC
56
11
NAVI
33
-8
PGR
49
4
SRE
40
3
MSI
54
2
PSA
45
2
STI
21
9
R
59
4
O
20
-6
NUE
39
2
HAL
30
-10
BMY
38
-3
CHRW
51
-2
AMG
49
14
TROW
42
3
QCOM
56
6
EQIX
57
-2
JCI
42
-2
DVN
24
2
FRT
36
2
KLAC
56
11
NAVI
33
-8
PGR
49
4
SRE
40
3
MSI
54
2
PSA
45
2
STI
21
9
Financhill
Back

Matthews International Vs. Viking Therapeutics Industry Stock Comparison

Sell
46

MATW
Matthews International

Last Price:
$27.69
Seasonality Move:
0.77%
Sell
24

VKTX
Viking Therapeutics

Last Price:
$42.08
Seasonality Move:
21.99%
Sell
46
Matthews International (MATW) is a Sell

Is Matthews International a Buy, Sell or Hold?

  • The current Matthews International [MATW] share price is $27.37. The Score for MATW is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • MATW is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $42.32. The Score for VKTX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MATW Stock Price Chart

What is Matthews International's stock price today?

  • The Matthews International share price today is $27.37
    The current trend is moderately bearish and MATW is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $42.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

MATW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.47 Buy
Relative Strength Index (14 RSI): 44.34 Sell
Chaikin Money Flow: -69566 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.62 - 31.22) Sell
Bollinger Bands (100): (22.35 - 27.87) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.12 Sell
Relative Strength Index (14 RSI): 34.11 Sell
Chaikin Money Flow: 1790477 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.93 - 52.95) Sell
Bollinger Bands (100): (51.14 - 67.26) Sell

MATW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.78 Sell
20-day SMA: 29.74 Sell
50-day SMA: 26.06 Buy
200-day SMA: 26.29 Buy
8-day EMA: 28.44 Sell
20-day EMA: 28.56 Sell
50-day EMA: 27.03 Buy
200-day EMA: 27.25 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.15 Sell
20-day SMA: 48.36 Sell
50-day SMA: 57.36 Sell
200-day SMA: 61.6 Sell
8-day EMA: 43.94 Sell
20-day EMA: 47.83 Sell
50-day EMA: 53.74 Sell
200-day EMA: 54.24 Sell

Matthews International Earnings Growth & MATW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.20 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.

Matthews International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):